NOTTINGHAM, UK – June 4th, 2025 – 4D Medicine Limited, a pioneering developer of advanced biomaterials for orthopaedic and surgical applications, is pleased to announce its participation as an exhibitor at the Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) 2025, taking place June 18–19 at the Donald E. Stephens Convention Center in Chicago, Illinois.

Attendees are invited to connect with 4D Medicine at Booth #558, where the company will be showcasing 4Degra®- its innovative bioabsorbable polymer platform that offers unprecedented performance in tissue repair and regeneration. This cutting-edge biomaterial, featuring novel polycarbonate urethane chemistry, is designed to meet the evolving needs of the orthopaedic, spine, and trauma markets. 

4D Medicine will be actively seeking sales channel partners for the Degrafix Interference Screw that delivers improved biocompatibility and more predictable resorption to increase surgeon confidence in long-term procedural success. The DegraFix interference Screw is the first product in a potential portfolio of improved soft tissue fixation devices.

“We are excited to engage with industry leaders and investors at OMTEC 2025,” said Phil Smith, CEO of 4D Medicine Limited. “Our materials offer unique advantages in terms of processibility, biocompatibility, and regenerative potential. We look forward to exploring strategic partnerships that will accelerate commercialization and expand clinical impact.”

Attendees are encouraged to schedule meetings in advance by contacting the 4D Medicine business development team at info@4dmedicine.co.uk.

For more information about 4D Medicine Limited and its novel biomaterial platform, please visit www.4dmedicine.co.uk.

ENDS

NOTTINGHAM, UK. 3rd April, 2025 – 4D Biomaterials Ltd, the materials manufacturing subsidiary of 4D Medicine Ltd, a UK university spin-out company developing next-generation bioresorbable medical devices, today announced it has achieved ISO 13485:2016 certification from The British Standards Institution (BSI). 

This globally recognised quality standard for medical device manufacturing marks a critical milestone in the company’s path to market, demonstrating high quality, low risk and customer-focused manufacturing capability. 

The certification confirms that 4D Biomaterials Ltd operates under a quality management system that meets stringent international regulatory requirements — a core prerequisite for the raw materials used in medical devices seeking regulatory approvals, clinical deployment, and global distribution. As such, certification significantly de-risks the company’s commercial strategy. 

Phil Smith, CEO of parent company, 4D Medicine Ltd commented:

“This achievement is a pivotal moment for our materials manufacturing business. ISO 13485 certification validates its operational systems and sends a clear signal to partners and investors: we are ready to scale. It also reflects the maturity of our technology platform, the discipline of our team, and our commitment to executing a high-quality commercialisation strategy.”

This milestone positions 4D to accelerate the development of commercial partnerships, regulatory approvals, and revenue-generating opportunities as it advances its differentiated product pipeline toward global markets.

ENDS

NOTTINGHAM, UK. March 11th, 2025 – 4D Medicine Ltd, an emerging innovator in the biomaterials and medical device sector, is proud to announce the launch of its newly redesigned corporate website, www.4dmedicine.co.uk.

The site is designed to offer a comprehensive resource for investors, strategic partners, and healthcare professionals, highlighting the company’s groundbreaking 4Degra® bioabsorbable polymer technology and its potential to transform the medical device industry.

The new website offers information on the unique properties of 4Degra®, a next-generation bioabsorbable polymer developed to improve patient outcomes in medical device applications. 4Degra®’s unparalleled versatility and biocompatibility make it an ideal material for a wide range of devices, including those used in musculoskeletal repair, soft tissue regeneration and drug-delivery.

“4Degra® represents the next evolution in bioabsorbable materials, and this website serves as an essential tool to communicate the exciting opportunities that lie ahead for investors and collaborators,” said Phil Smith, CEO of 4D Medicine. 

“We’ve designed the site to not only inform but to also demonstrate the potential impact our technology can have in improving surgical outcomes and improving lives.”

Key features of the new website include:

The launch of this website underscores 4D Medicine’s commitment to transparency, collaboration, and ongoing innovation. The company is poised to lead the way in delivering solutions that enhance patient care and create lasting value for its partners and stakeholders.

ENDS

LOS ANGELES, USA. June 6th, 2024 – Next Health, known for its state-of-the-art personalized treatments for health optimization and longevity, has announced its expansion into Las Vegas through a multi-unit area development agreement encompassing both Summerlin and Henderson. 

Franchised by seasoned entrepreneurs Bo Thede and Zach Mendelsohn, Next Health locations will open in 2025 to meet the rapidly growing demand for personalized wellness, aesthetics, recovery technology, and advanced longevity services.

Clark County locations are uniquely positioned to achieve sustainable recurring revenue by servicing the diverse resident population, with substantial incremental growth from the ever-present global tourism audience. This, in addition to Next Health’s high average gross profit margin, solidified the company’s expansion into Nevada by Bo and Zach.

Co-founders Dr. Darshan Shah (CEO) and Kevin Peake (President) said: “Next Health will revolutionize the way Las Vegas residents and visitors manage their health. Las Vegas locations will centralize and elevate the quality of services that customers know and love, such as IV therapy, cryotherapy, and aesthetics, but will also provide access to the latest advancements in health optimization and longevity that aren’t available anywhere else, promoting long-term vitality.”

This growth builds upon Next Health’s established success as the global industry leader, with 55 locations open or in development across 11 states and four countries.

Chief Operating Officer Scott Svilich said: “Next Health’s industry-leading unit economics, paired with our real estate and development strategies and phenomenal Franchise Support Team, make Next Health a truly a one-of-a-kind franchise concept. As we continue to expand into tier-one markets globally, we’re exclusively partnering with franchisees that showcase proven entrepreneurial strengths, passion for our mission, and authentic alignment with their market. Bo and Zach exemplify that synergy perfectly.”

Explore Next Health franchising opportunities on its Franchise Website or by emailing franchise@next-health.com.

ENDS

Revolutionizing Chronic Pain Management: The Power of Augmented Reality

WEST MIDLANDS, UK. March 11th, 2024 – In a groundbreaking advancement for chronic pain treatment, the integration of Apple Vision Pro augmented reality (AR) goggles into ultrasound-guided pain relief procedures marks a significant leap forward in patient care. This innovative approach has not only enhanced the precision and efficiency of interventions but also significantly improved patient comfort and experience. Delivered exclusively at The Vesey Private Hospital, this revolutionary treatment is safer, quicker and more efficient. The Treatment was delivered by Dr Arul James MBBS, MD, FRCA, FFPMRCA, Consultant Chronic Pain Medicine, who is clinical lead for Pain Management services at The Vesey.

Understanding Chronic Pain and Its Challenges

Chronic pain is a complex condition that affects millions worldwide, significantly impacting their quality of life. While medical, holistic, and self-management strategies offer some relief, they often fall short of fully addressing the pain. In these cases, targeted interventions like joint injections, nerve blocks, trigger point injections, and deep muscle plane injections become crucial. Traditionally, these procedures relied heavily on the clinician’s skill in manipulating the ultrasound probe and needle while alternating their gaze between the patient and the ultrasound screen—a method that posed limitations on precision and comfort.

Augmented Reality: A Game Changer in Pain Management

The introduction of AR goggles has transformed this scenario by allowing clinicians to simultaneously view a virtual ultrasound screen within their field of vision and the actual procedure site. This dual visibility ensures uninterrupted focus on both the sonoanatomy displayed by the ultrasound and the precise manipulation of the probe and needle.

Enhanced Procedure Efficiency

Utilizing AR technology can potentially lead to a noticeable reduction in the duration of procedures and the number of attempts required to accurately position the needle. This improvement not only speeds up the treatment process but also minimises patient discomfort, making the experience more bearable and less daunting.

Improved Patient Comfort and Experience

The ability to adjust the virtual ultrasound screen’s location, size, and proximity according to the operator’s preference can significantly enhance the comfort and accuracy of procedures. This customisation can ensure the best possible patient outcomes, making the entire process smoother and more comfortable.

Looking Ahead: The Future of Pain Management

The successful integration of AR technology in chronic pain interventions represents a promising direction for the future of medical procedures. By improving accuracy, efficiency, and patient experience, augmented reality paves the way for more advanced and humane approaches to pain management.

This breakthrough highlights the potential of combining technology and healthcare to create solutions that are not only effective but also empathetic towards patient needs. As we continue to explore and innovate, the horizon for chronic pain treatment looks brighter and more hopeful than ever. 

If you have an interest in managing your own pain, Dr James is a published author, and has developed a patient centred book designed to help patient’s manage symptoms. His research,
Empowering Pain Management: A Comprehensive Practical Guide to Mastering Life with Chronic Pain, is available here.

If you would like to see a specialist at the Vesey Hospital, appointments can be booked online here.